Carbon Monoxide Poisoning: Evidence‑Based Management

Immediate Management

• Administer 100 % oxygen immediately via a non‑rebreather mask or endotracheal tube as soon as carbon‑monoxide (CO) poisoning is suspected, without waiting for laboratory confirmation. 1, 2

Clinical Diagnosis

• Diagnosis relies on three components: (1) a history of CO exposure, (2) compatible symptoms (e.g., headache, dizziness, nausea, confusion, chest pain, shortness of breath, loss of consciousness), and (3) an elevated carboxy‑hemoglobin (COHb) level; the elevated COHb confirms the diagnosis but does not reliably predict symptom severity or prognosis. 1, 2, 3, 4

Laboratory Testing

• COHb should be measured by spectrophotometric CO‑oximetry on either arterial or venous blood; levels are comparable between the two sample types. 2
• COHb ≥ 3–4 % in nonsmokers and ≥ 10 % in smokers is considered abnormal. 2
• Non‑invasive pulse CO‑oximetry is not recommended for diagnosis because it shows poor agreement with blood COHb values and tends to underestimate true levels. 5

Additional Work‑up for Severe Cases

• Obtain an arterial blood gas when metabolic acidosis is suspected. 2
• Measure plasma lactate; a lactate > 10 mmol/L in fire‑victim exposures raises suspicion for cyanide co‑poisoning. 1, 3
• In intentional CO ingestions, perform a toxicological screen for co‑ingestants. 1, 3

Normobaric Oxygen Therapy (NBOT)

• Continue 100 % oxygen until both (a) COHb falls below 3 % and (b) the patient is asymptomatic; a minimum treatment duration of 6 hours is recommended. 1, 3, 4, 6

Hyperbaric Oxygen Therapy (HBOT)

Indications (Strong)

• Consider HBOT (initiated within 6 hours when possible) for patients with any of the following: loss of consciousness, persistent neurological deficits, evidence of cardiac ischemia, significant metabolic acidosis, or COHb > 25 %. 1, 3, 4, 7

Indications (Relative)

• HBOT may be used at physician discretion for patients with persistent symptoms despite NBOT or for individuals aged ≥ 36 years with ≥ 24 hours of exposure. 1, 3, 8

Protocol & Goal

• Recommended regimen: up to three HBOT sessions within 24 hours for patients who remain symptomatic after NBOT. The primary goal is prevention of neurocognitive sequelae. 1, 3, 7

Evidence Strength

• The 2017 American College of Emergency Physicians (ACEP) guideline gives a Level B recommendation that emergency physicians may use either HBOT or high‑flow NBOT; superiority of HBOT for long‑term neurocognitive outcomes remains uncertain. 5
• The highest‑quality randomized trial (Weaver 2002) demonstrated that HBOT reduced cognitive sequelae to 25 % versus 46 % with NBOT at 6 weeks, with benefits persisting to 12 months. 9, 8

Follow‑Up Care

• All patients should be reassessed at 4–6 weeks to screen for delayed neurological sequelae, as cognitive dysfunction can emerge after apparent recovery. 1, 3, 4
• Patients with intentional CO poisoning require mandatory psychiatric follow‑up due to a high risk of subsequent suicide. 1, 3, 4

Critical Pitfalls to Avoid

• Do not delay oxygen therapy while awaiting COHb results. 1, 2
• Do not base treatment duration or prognostication solely on COHb levels. 1, 3, 4
• Do not rely on “cherry‑red” skin discoloration as a diagnostic clue; it is rare and occurs only at lethal COHb concentrations. 1, 2
• In fire‑related exposures, consider cyanide co‑poisoning when arterial pH < 7.20 or lactate > 10 mmol/L. 1, 3

Management of Mild Carbon Monoxide Poisoning in Healthy Adults

Pharmacokinetics of Carboxyhemoglobin

• High‑flow 100 % normobaric oxygen reduces the half‑life of carboxyhemoglobin to approximately 85 minutes, compared with 4–5 hours on room air, facilitating faster clearance of CO exposure【10】.

Neurocognitive Sequelae

• In patients with “mild” CO poisoning (COHb < 20 % and brief exposure), the incidence of cognitive deficits at 6 weeks is comparable to that of severely poisoned patients, indicating that severity of initial COHb does not predict long‑term neurocognitive outcome【11】【12】.
• Delayed neurological symptoms (e.g., memory loss, concentration impairment, depression, parkinsonism) may appear 2–21 days after exposure in 12 %–68 % of cases, underscoring the need for vigilant follow‑up【10】.

Hyperbaric Oxygen (HBO₂) Considerations

• Indications for HBO₂ in mild cases (based on expert consensus):
• Because the majority of individuals lack the APOE ε4 allele (a predictor of poor HBO₂ response), some experts advocate HBO₂ for all acute CO poisoning cases, including mild presentations【11】【12】.

HBO₂ Treatment Protocol

• When employed, HBO₂ is initiated within 6 hours of presentation when feasible.
• The typical regimen consists of up to three sessions within 24 hours for patients who remain symptomatic.
• Treatments are commonly delivered at 3.0 atm absolute pressure, aiming to prevent neurocognitive dysfunction rather than to affect short‑term mortality【11】.

Mortality and Outcome

• Overall mortality from acute CO poisoning is approximately 3 %, and this rate does not differ significantly between normobaric oxygen and HBO₂ therapy, highlighting that the primary benefit of HBO₂ is neuroprotection【11】.

Follow‑Up Recommendations

• All patients should be reassessed at 4–6 weeks post‑exposure to screen for delayed neurological sequelae, even if they appeared fully recovered initially【10】.

Evidence Strength

• The 2017 ACEP guideline assigns a Level B (moderate) recommendation that emergency physicians may use either HBO₂ or high‑flow normobaric oxygen, reflecting moderate evidence for the benefit of HBO₂ on long‑term outcomes【10】.
• The 2012 practice recommendations acknowledge significant controversy regarding HBO₂ use in mild poisoning, indicating that the evidence base, while suggestive, remains unsettled【11】【12】.